Essential Partners LLC
Position in TAK — Takeda Pharmaceutical Co Ltd
CIK 2136442
RANCHO SANTA FE, CA
Position in TAK
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$37,221
+$17,090 QoQ
Shares Held
2,322
+113.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#257
of 375 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Essential Partners LLC holds $782,672 across 37 Drug Manufacturers - Specialty & Generic names. TAK ranks #5 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
2,060 | $347,192 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
289 | $156,588 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
684 | $43,741 | |
| 4 | VTRS |
Viatris Inc
|
2,505 | $39,779 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
2,322 | $37,221 | |
| 6 | ZTS |
Zoetis Inc.
|
464 | $33,343 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
6,232 | $26,236 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
1,091 | $18,885 |
All Filings in TAK
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,221 | 2,322 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $20,131 | 1,087 | Shares | Sole | 2026-05-21 | |
| 2025-12-31 | $13,641 | 875 | Shares | Sole | 2026-05-21 | |
| 2025-09-30 | $21,432 | 1,464 | Shares | Sole | 2026-05-21 | |
| No filing history on record for this holder in this stock. | ||||||